TrialJournal of neurodevelopmental disorders2020

Controlled trial of lovastatin combined with an open-label treatment of a parent-implemented language intervention in youth with fragile X syndrome.

Angela John Thurman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.